A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

被引:16
作者
Lin, Hao [1 ]
Ren, Guoqiang [2 ]
Liang, Xiaohua [3 ]
机构
[1] Fudan Univ, Dept Oncol, Huashan Hosp North, Shanghai, Peoples R China
[2] Fudan Univ, Dept Pathol, Huashan Hosp North, Shanghai, Peoples R China
[3] Fudan Univ, Dept Oncol, Huashan Hosp, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China
关键词
CANCER;
D O I
10.1016/j.jtho.2018.07.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E234 / E236
页数:4
相关论文
共 3 条
[1]   Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer [J].
Peters, Solange ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Gadgeel, Shirish ;
Ahn, Jin S. ;
Kim, Dong-Wan ;
Ou, Sai-Hong I. ;
Perol, Maurice ;
Dziadziuszko, Rafal ;
Rosell, Rafael ;
Zeaiter, Ali ;
Mitry, Emmanuel ;
Golding, Sophie ;
Balas, Bogdana ;
Noe, Johannes ;
Morcos, Peter N. ;
Mok, Tony .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :829-838
[2]   Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer [J].
Soda, Manabu ;
Choi, Young Lim ;
Enomoto, Munehiro ;
Takada, Shuji ;
Yamashita, Yoshihiro ;
Ishikawa, Shunpei ;
Fujiwara, Shin-ichiro ;
Watanabe, Hideki ;
Kurashina, Kentaro ;
Hatanaka, Hisashi ;
Bando, Masashi ;
Ohno, Shoji ;
Ishikawa, Yuichi ;
Aburatani, Hiroyuki ;
Niki, Toshiro ;
Sohara, Yasunori ;
Sugiyama, Yukihiko ;
Mano, Hiroyuki .
NATURE, 2007, 448 (7153) :561-U3
[3]   Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer [J].
Yoshida, Tatsuya ;
Oya, Yuko ;
Tanaka, Kosuke ;
Shimizu, Junichi ;
Horio, Yoshitsugu ;
Kuroda, Hiroaki ;
Sakao, Yukinori ;
Hida, Toyoaki ;
Yatabe, Yasushi .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) :3383-+